Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.49 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 4/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23839 | 0.92 | MAOA (0.57) | MAOADNMT1CES1BCHEALDH1A1 | |
| SCHEMBL5680075 | 0.79 | MAOA (0.49) | MAOACES1BCHEALDH1A1CYP1A2 | |
| SCHEMBL867598 | 0.79 | DNMT1 (0.44) | MAOADNMT1CES1ALDH1A1CYP2C19 | |
| SCHEMBL29520144 | 0.79 | DNMT1 (0.44) | MAOADNMT1CES1ALDH1A1CYP2C19 | |
| SCHEMBL10703055 | 0.78 | MAOA (0.59) | MAOACES1BCHEALDH1A1CYP1A2 | |
| SCHEMBL9099089 | 0.77 | METAP1 (0.50) | MAOADNMT1CES1ALDH1A1CYP1A2 | |
| SCHEMBL11661562 | 0.77 | METAP1 (0.50) | MAOADNMT1ALDH1A1CYP1A2MAPT | |
| SCHEMBL7736589 | 0.75 | NSD2 (0.45) | MAOADNMT1CES1ALDH1A1CYP1A2 | |
| SCHEMBL11662672 | 0.75 | MAOA (0.47) | MAOACES1BCHEALDH1A1CYP1A2 | |
| SCHEMBL11037499 | 0.75 | MAOA (0.47) | MAOACES1BCHEALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10073349-B2 | Chemically amplified resist material, pattern-forming method, compound, and production method of compound | OSAKA UNIVERSITY (JP) | 2018-09-11 | — | — | US | disclosed |
| US-20170052449-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND | OSAKA UNIVERSITY (JP) | 2017-02-23 | — | — | US | disclosed |
| EP-3133444-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND | OSAKA UNIVERSITY (JP) | 2017-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10073349-B2 | Chemically amplified resist material, pattern-forming method, compound, and production method of compound | RER1, POLR1A, FEM1B | MAOA 1117/4885DNMT1 332/4885CES1 4195/4885 |
| US-20170052449-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND | RER1, POLR1A, FEM1B | MAOA 1117/4885DNMT1 332/4885CES1 4195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.